URL: http://cgp.iiarjournals.org
Publisher: International Institute of Anticancer Research
Online ISSN: 1790-6295
Print ISSN: 1109-6535
additional details

HighWire Press and the International Institute of Anticancer Research (IIAR) are pleased to announce that the full text of CANCER GENOMICS & PROTEOMICS is now available online.

CANCER GENOMICS & PROTEOMICS (CGP) is an international, peer-reviewed journal devoted to the rapid publication of original high quality articles and reviews on the applications of genomic and proteomic technology to basic, experimental and clinical cancer research. The first issue of CGP circulated in January 2004. The journal's scientific spectrum includes: (a) molecular causes of carcinogenesis, cancer progression and metastasis; (b) structural and functional aspects of genes in the cancer cell; (c) advances in genomic and proteomic technologies applicable to cancer research; (d) anticancer drug design and drug development. CGP also publishes abstracts and proceedings of scientific meetings.

Articles in CGP are regularly indexed in PubMed, Medline, Chemical Abstracts Service, Biological Abstracts, EMBASE and BIOBASE, Compendex, GEOBASE, EMBiology, Elsevier Bibliographic Databases, BIOSIS Previews, Leeds Medical Information, CSA Illumina, VINITI, PubsHub, SIIC.

CGP supports (a) the aims and research projects of the INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH and (b) the organization of the International Conferences of Anticancer Research.

Bi-Monthly

---------------------------------

The online edition of CANCER GENOMICS & PROTEOMICS contains full text articles and PDFs for each issue. Issues will be placed online approximately on the date they are mailed to subscribers; therefore the online issues may be available prior to receipt of your paper copy. Online readers may want to sign up for the eTOC (electronic Table of Contents) alerting service, which will deliver each new issue's table of contents via email. The web site also provides access to information about the journal and a link to the International Institute of Anticancer Research http://www.iiar-anticancer.org.

Access to the full text of articles will be available by institutional or individual subscription. All other access (e.g., to the home page, tables of contents, yearly indices, book reviews, NCI articles, conference abstracts, Errata and searching) will remain freely available.

--John G. Delinassios,
Director, International Institute of Anticancer Research

--John Sack,
Director, HighWire Press, Stanford University